Cosmetic Physician Partners, LLC
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$204K
Investors
—
Min Invest
$204,284
What this filing shows
·Every sentence is a value as filed on SEC Form D
Cosmetic Physician Partners, LLC is a Delaware limited liability company organized in 2021 that first filed a Form D on December 6, 2021 and most recently amended it on October 14, 2026 in the Other Health Care industry group. The offering claims Rule 506(b). Cosmetic Physician Partners, LLC reported $204,284 sold of a $204,284 total offering as of the Form D filed October 14, 2026. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $204,284. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 8226 Douglas Avenue, Ste 104, Dallas, TX 75225.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
Fund Family
Every vehicle in this manager's series as it appears on EDGAR, newest generation first. Sold-to-date and investor counts are each vehicle's latest Form D.
Fund family
Cosmetic Physician Partners1 vehicle · 0 generations · since 2021 · $40.2M sold across the family
| Vehicle | Role | First filed | Status | Sold | Investors |
|---|---|---|---|---|---|
| Unnumbered · first filed 2026-10-14 · 1 vehicle · $204K sold | |||||
| Cosmetic Physician Partners, LLCthis issuer | 2026-10-14 | closed | $204K | 0 | |
Grouped from Form D issuer names (generation, sleeve, jurisdiction and legal-form tokens removed); a name-only match, so abbreviated or renamed vehicles can be missed. Sold and investor figures are each vehicle's latest Form D; sleeves that report the same figure share one family-wide total and are counted once. Performance lines are what a public pension plan reports for its own interest in that fund, net, on the plan's cash flows and valuation date; they are not the general partner's figures.
In the Terminal
Filing events
9
latest Oct 14, 2026
Critical / warning
0 / 0
2 watch · 7 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
11
pre_sale, raising, closed
Latest event New filer · Oct 14, 2026
SEC.govInvestor
- 9 filing events with values and deltas, latest 2026-10-14, and alerts on the next one
- 11 offering timelines: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Jeffrey Hart
Director · Westmount, A8
2. Jeffrey Baikowitz
Director · Westmount, A8
3. Matthew Taranto
Director · Kansas City, MO
Charles Flicker
Director · Toronto, A6
Adam Sokoloff
Director · New York, NY
Justin Puckett
Director · Southlake, TX
Jodi Kessler
Director · Toronto, A6
Daniel Schacter
Executive Officer, Director · Montreal, A8
Daniel Muroff
Executive Officer · Montreal, A8
Ngo Antoine
Executive Officer · Montreal, A8
Justin Cohen
Executive Officer · Montreal, A8
Sean Walsh
Executive Officer · Calgary, A0
James Stanford
Executive Officer · Dallas, TX
Holly Christopher
Executive Officer · Shiloh, IL
Questions About Cosmetic Physician Partners, LLC
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is Cosmetic Physician Partners, LLC?
Cosmetic Physician Partners, LLC is a Delaware limited liability company organized in 2021 that filed a Form D with the SEC on October 14, 2026 in the Other Health Care industry group. The filing claims Rule 506(b).
Is Cosmetic Physician Partners, LLC legit?
AltStreet does not rate legitimacy; it reports the public record. Cosmetic Physician Partners, LLC filed a Form D with the SEC on October 14, 2026 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $204,284 sold. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is Cosmetic Physician Partners, LLC registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Cosmetic Physician Partners, LLC claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has Cosmetic Physician Partners, LLC raised?
Cosmetic Physician Partners, LLC reported $204,284 sold of a $204,284 total offering as of the Form D filed October 14, 2026.
Who can invest in Cosmetic Physician Partners, LLC?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $204,284.
What is the minimum investment in Cosmetic Physician Partners, LLC?
The Form D lists $204,284 as the minimum investment accepted from any outside investor as of October 14, 2026. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling Cosmetic Physician Partners, LLC and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.
Who is behind Cosmetic Physician Partners, LLC?
The Form D lists 14 related persons: Jeffrey Hart, director; 2. Jeffrey Baikowitz, director; 3. Matthew Taranto, director; Charles Flicker, director; Adam Sokoloff, director; Justin Puckett, director; Jodi Kessler, director; Daniel Schacter, executive officer, director, and 6 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is Cosmetic Physician Partners, LLC located?
The issuer's address on its SEC filings is 8226 Douglas Avenue, Ste 104, Dallas, TX 75225. Its phone number of record is 9133200878. It is organized under the laws of Delaware.
How long is the Cosmetic Physician Partners, LLC offering open?
The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.
What is Cosmetic Physician Partners, LLC's revenue?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.